Companies Pfizer Inc FollowDec 16 (Reuters) - A federal judge on Friday tossed a lawsuit by a group of medical professionals alleging a fellowship program established by Pfizer Inc (PFE.N) to improve diversity within its higher ranks discriminates against white and Asian-American applicants.
Do No Harm, a group opposed to what it calls "radical, divisive, and discriminatory ideologies" in healthcare, alleged the drugmaker's Breakthrough Fellowship Program was discriminatory because only Blacks, Latinos and Native Americans could apply.
Pfizer in a statement welcomed the ruling, saying it was "proud of its commitment to diversity, equity, and inclusion."
Pfizer launched the fellowship in 2021.
Fellows receive two years of full-time jobs, fully funded master's degrees, and employment at New York-based Pfizer after completing the program.